Gynecological cancer metastasized to the lungs?
Hello, Doctor! My mother was diagnosed with vulvar cancer 7-8 years ago and underwent surgery to remove the tumor.
It recurred two years later, requiring another surgery and radiation therapy.
Last year, several tumors were found in her lungs, and her gynecologic oncologist assessed that the cancer cells likely spread through the bloodstream but developed slowly.
A PET scan showed tumors only in the lungs.
Since April, she has undergone 12 chemotherapy sessions (11 with paclitaxel and carboplatin, and 1 with gemcitabine).
The 12th session was originally planned to switch to nanoliposomal irinotecan and cisplatin, but it caused severe allergic shock, so she was switched to gemcitabine alone.
The gynecologic oncologist mentioned that there are not many good medications covered by insurance, implying a recommendation for targeted therapy.
However, targeted therapy may not necessarily be effective, and we are uncertain about the number of treatments required, which poses a significant financial burden for us (as we do not have a reimbursement insurance plan).
Due to chemotherapy, the thoracic surgeon indicated that the tumors have shrunk.
I would like to ask: (1) If surgery is an option, should we consider proceeding with surgery first? (2) If I undergo surgery, I will likely still need chemotherapy afterward; can we pause the current chemotherapy before surgery? Chemotherapy has made her very weak, and I am concerned about how she will cope with major surgery.
(3) Besides targeted therapy, are there any other options available? (My mother's kidney function is not very good.) I apologize for the lengthy questions, but I am unsure how to discuss the next steps with her oncologist, so I hope to seek your thoughts and suggestions.
Thank you very much!
Mo Mo, 40~49 year old female. Ask Date: 2020/02/02
Dr. Chen Yunfang reply Oncology
Hello: There are no textbook-standard answers to these three questions; the responses can vary for each patient even under similar circumstances.
1.
The risk assessment and outcomes of surgery are not something I can explain; that should be addressed by the surgeon.
2.
The decision to initiate or discontinue chemotherapy is made by the original physician.
3.
Any changes to chemotherapy should also be determined by the original physician.
There are no standard answers, and I recommend that you have a thorough discussion with the attending physician.
It is the physician's responsibility to explain the condition and treatment plan, as no patient would agree to such significant medical interventions without a clear understanding.
Thank you.
Reply Date: 2020/02/02
More Info
Understanding lung metastasis from gynecological cancers, such as vulvar cancer, involves a complex interplay of treatment options and considerations that must be tailored to the individual patient's condition. Your mother's medical history indicates a challenging journey, having undergone multiple surgeries and chemotherapy treatments over the years. The presence of lung tumors suggests that the cancer has metastasized, which complicates treatment decisions.
1. Surgical Considerations: If the lung tumors are operable, surgery may be a viable option. Surgical resection can provide a chance for long-term survival, especially if the tumors are isolated and have not spread extensively. However, the decision to proceed with surgery should be made in consultation with a thoracic surgeon and an oncologist. They will assess the size, location, and number of tumors, as well as the overall health of your mother, including her lung function and any other comorbidities. If surgery is deemed appropriate, it may be beneficial to consider it before further chemotherapy, as removing the tumors could potentially lead to a better outcome.
2. Chemotherapy Management: Regarding the current chemotherapy regimen, it is essential to discuss with the oncologist whether it is advisable to pause chemotherapy before surgery. Chemotherapy can weaken the body, making it more challenging to recover from surgery. The oncologist may recommend a break in treatment to allow your mother to regain strength before undergoing surgery. However, this decision should be based on the timing of the surgery and the aggressiveness of the cancer. If the chemotherapy is effectively shrinking the tumors, it may be beneficial to continue until surgery is scheduled.
3. Alternative Treatment Options: In addition to targeted therapies, there may be other options available depending on the specific characteristics of the cancer. For instance, immunotherapy has emerged as a promising treatment for various cancers, including some gynecological cancers. Clinical trials may also be an option worth exploring, as they can provide access to new therapies that are not yet widely available. Given your mother's renal function concerns, it is crucial to discuss any potential treatments with her healthcare team to ensure they are safe and appropriate for her condition.
4. Financial Considerations: The financial burden of cancer treatment is a significant concern for many families. It is advisable to discuss these concerns openly with the healthcare team. They may be able to provide resources or refer you to financial counselors who can assist in navigating insurance options, potential financial aid, or support programs that may alleviate some of the financial stress.
5. Communication with Healthcare Providers: It is essential to maintain open lines of communication with your mother's healthcare providers. Prepare a list of questions and concerns before appointments to ensure that all aspects of her treatment plan are addressed. If you feel that your mother's needs are not being met or that you require more information, consider seeking a second opinion from another oncologist or a specialized cancer center.
In summary, the management of lung metastasis from gynecological cancer requires a multidisciplinary approach. Surgical options should be carefully evaluated, and the timing of chemotherapy in relation to surgery is critical. Exploring alternative treatments and maintaining clear communication with healthcare providers will be vital in navigating this challenging journey. Your mother's well-being and quality of life should remain the primary focus throughout her treatment.
Similar Q&A
Understanding Treatment Options for Metastatic Cervical Cancer
Dear Doctor: My mother was diagnosed with stage IIB cervical cancer in September 2017 and underwent chemotherapy (cisplatin) and radiation therapy (both internal and external). In March 2020, after discovering brain metastasis, she underwent surgery to remove the brain tumor. In ...
Dr. Lin Xinwang reply Obstetrics and Gynecology
Hello, Feng: 1. First of all, imaging studies have their limitations; positron emission tomography (PET) may not detect very small metastatic cancer cells, and the same applies to computed tomography (CT). Therefore, clinical assessment is usually still necessary. Based on your...[Read More] Understanding Treatment Options for Metastatic Cervical Cancer
Advanced Cervical Cancer Treatment Options and Patient Care Insights
1. Given the current medical technology, your mother may be eligible for various treatment options, including targeted therapy, immunotherapy, or clinical trials, depending on her specific condition and the characteristics of the tumor. 2. If the tumor is too large or if the can...
Dr. Cai Yonglong reply Obstetrics and Gynecology
Dear Flyliv, As you mentioned, it is suspected that your mother may be in the advanced stage of cervical cancer, which often leads to edema and uremia. Post-surgery radiation therapy is typically the most effective treatment, while chemotherapy tends to have limited efficacy. It...[Read More] Advanced Cervical Cancer Treatment Options and Patient Care Insights
Understanding Lung Metastasis in Breast Cancer: Key Questions Answered
Hello Dr. Chang, I am the brother of your patient, Liu Huijuan. I work in obstetrics and gynecology and am currently employed in Taipei. Recently, I was very anxious when my sister was found to have a lung mass. As her brother, being far away makes me feel guilty for not being ab...
Dr. Zhang Zhenxiang reply Surgery
Director Zhang from the Surgery Department has responded via mobile phone.[Read More] Understanding Lung Metastasis in Breast Cancer: Key Questions Answered
Monitoring Lung Adenocarcinoma: Key Insights and Next Steps
Dear Dr. Chen, I am a patient with lung adenocarcinoma. On May 21 of this year, I underwent surgery to remove a malignant tumor (2.2 cm) from my right upper lobe and a nodule from the same side lower lobe. The biopsy of the right lower lobe nodule also confirmed malignancy. A PE...
Dr. Chen Yunfang reply Oncology
Hello: Based on the provided information, the reliability and accuracy of the three types of examinations are best with positron emission tomography (PET scan), which is the second option. Both the first option, computed tomography (CT scan), and the third option, magnetic resona...[Read More] Monitoring Lung Adenocarcinoma: Key Insights and Next Steps
Related FAQ
(Oncology)
Ovarian Tumor(Oncology)
Uterus(Oncology)
Cancer Treatment(Oncology)
Nasopharyngeal Cancer(Oncology)
Postoperative Lung Adenocarcinoma(Pulmonology)
Endometrial Cancer(Obstetrics and Gynecology)
Pancreatic Cancer(Oncology)
Thrombocytosis(Oncology)
Lymphadenopathy(Oncology)